SkinBioTherapeutics Appoints Interim CEO

Rachel Parsonage appointed as interim CEO of SkinBioTherapeutics, a life sciences company focused on skin health. Parsonage, with over 25 years of experience in beauty and wellness, will lead the company through a critical period following the resignation of former CEO Stuart Ashman. Ashmans departure was due to sharing misleading information, leading to a drop in share price and an internal investigation. Parsonage will join the board once routine checks are complete, as the company works to stabilize operations and clear up uncertainties. Support the showGet a discount at https://solipillow.com/discount/dnn. Advertise on [email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected] View sources & latest updateshttps://sources.thednn.ai/c795ce00e4ab0f24